SARS-CoV-2 and guttate psoriasis: A case report and review of literature.

COVID‐19 SARS‐CoV‐2 guttate psoriasis psoriasis

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 06 2021
accepted: 23 06 2021
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 24 7 2021
Statut: epublish

Résumé

Guttate psoriasis is a rare dermatological presentation of SARS-CoV-2 infection and is seen mainly in patients with an underlying disease psoriasis.

Identifiants

pubmed: 34295501
doi: 10.1002/ccr3.4568
pii: CCR34568
pmc: PMC8283862
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e04568

Informations de copyright

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

All authors have no conflict of interest.

Références

J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Acta Biomed. 2020 Nov 10;91(4):e2020164
pubmed: 33525211
BMJ Case Rep. 2020 Jun 7;13(6):
pubmed: 32513768
J Am Acad Dermatol. 2020 Oct;83(4):1118-1129
pubmed: 32622888
Trends Immunol. 2009 Oct;30(10):494-501
pubmed: 19781993
J Dermatol. 2010 Oct;37(10):894-9
pubmed: 20860740
Heart Views. 2020 Jul-Sep;21(3):187-192
pubmed: 33688410
J Am Acad Dermatol. 2020 Jul;83(1):e57-e60
pubmed: 32339706
BMJ Case Rep. 2020 Aug 11;13(8):
pubmed: 32784237
Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-8
pubmed: 15180464
Dermatol Ther. 2020 Nov;33(6):e13858
pubmed: 32686245
Clin Exp Dermatol. 2001 Jun;26(4):326-32
pubmed: 11422184
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Front Cardiovasc Med. 2021 Jan 08;7:598846
pubmed: 33585578
Am J Case Rep. 2020 Oct 13;21:e925932
pubmed: 33046686
Acta Biomed. 2020 Sep 07;91(3):e2020010
pubmed: 32921708
Clin Case Rep. 2021 Jan 07;9(3):1202-1206
pubmed: 33768811
Br J Dermatol. 2019 Dec;181(6):1304-1306
pubmed: 31150103
Acta Derm Venereol. 2007;87(4):335-40
pubmed: 17598037

Auteurs

Elrazi Ali (E)

Internal Medicine Department Hamad Medical Corporation Doha Qatar.

Abdelaziz Mohamed (A)

Internal Medicine Department Hamad Medical Corporation Doha Qatar.

Joud Abuodeh (J)

Internal Medicine Department Hamad Medical Corporation Doha Qatar.

Mhd Kutaiba Albuni (MK)

Internal Medicine Department Hamad Medical Corporation Doha Qatar.

Najlaa Al-Mannai (N)

College of Medicine Qatar University Doha Qatar.

Sarah Salameh (S)

Infectious Disease Department Hamad Medical Corporation Doha Qatar.

Mahir Petkar (M)

Histopathology Department Hamad Medical Corporation Doha Qatar.

Elmukhtar Habas (E)

Internal Medicine Department Hamad Medical Corporation Doha Qatar.

Classifications MeSH